Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

The prescription drug has been all over the news in the past couple of years - but the name Ozempic has become something of a ...

Even though there is no official Ozempic Diet, there are certain foods you can avoid to minimize your chances of negative ...

Losing weight may seem simple: engage in regular physical activity and exercise and eat a balanced diet that contains ...

Finding the right solution for weight loss can feel overwhelming, especially with so many options available. While ...

Currently, the only FDA-approved OTC weight loss drug is Alli, which uses a 60-milligram dose of orlistat versus 120 ...

However, as of September 2024, the FDA has marked all Zepbound doses as available. One alternative may be Wegovy, another FDA-approved drug for weight ... people get the best price possible ...

The pills used to help treat PE are used off-label, meaning the use is not approved by the FDA. However, there is some evidence that the pills work. PE pills work best when used along with ...

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injections as an add-on therapy for certain adults with poorly controlled chronic obstructive pulmonary disease (COPD).

A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...